Executives Should Think Twice Before Accepting Pleas 'Relating to Fraud': The Expansion of Exclusion Under the Park Doctrine

FDA Announces Implementation of "Remote Interactive Evaluations" of Drug Manufacturing Establishments and Biomedical Research

Life Sciences 2021 Guide